| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |